Cargando…

Donor-transmitted melanoma after limbal stem cell transplantation

Limbal Stem Cells are a unique cell line located at the corneal limbus. They are responsible for regenerating and restoring corneal epithelial layers. Limbal stem cell transplantation is a promising technique that has been used to treat several hereditary and acquired corneal diseases. Cornea tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsara, Anas, Rafi, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398008/
https://www.ncbi.nlm.nih.gov/pubmed/28469991
http://dx.doi.org/10.4103/2231-0770.203609
_version_ 1783230382307540992
author Alsara, Anas
Rafi, Muhammad
author_facet Alsara, Anas
Rafi, Muhammad
author_sort Alsara, Anas
collection PubMed
description Limbal Stem Cells are a unique cell line located at the corneal limbus. They are responsible for regenerating and restoring corneal epithelial layers. Limbal stem cell transplantation is a promising technique that has been used to treat several hereditary and acquired corneal diseases. Cornea tissue lack vascularity. Hence, there were no special restrictions on collecting ocular tissues from donors with a diagnosis of metastatic melanoma. We are reporting a case of a patient who developed an ocular melanoma after she had limbal stem cell transplantation from a donor with history of melanoma. After this case, Eye Bank Association of America updated the donor criteria to exclude donors with any history of melanoma.
format Online
Article
Text
id pubmed-5398008
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-53980082017-05-03 Donor-transmitted melanoma after limbal stem cell transplantation Alsara, Anas Rafi, Muhammad Avicenna J Med Case Report Limbal Stem Cells are a unique cell line located at the corneal limbus. They are responsible for regenerating and restoring corneal epithelial layers. Limbal stem cell transplantation is a promising technique that has been used to treat several hereditary and acquired corneal diseases. Cornea tissue lack vascularity. Hence, there were no special restrictions on collecting ocular tissues from donors with a diagnosis of metastatic melanoma. We are reporting a case of a patient who developed an ocular melanoma after she had limbal stem cell transplantation from a donor with history of melanoma. After this case, Eye Bank Association of America updated the donor criteria to exclude donors with any history of melanoma. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5398008/ /pubmed/28469991 http://dx.doi.org/10.4103/2231-0770.203609 Text en Copyright: © 2017 Avicenna Journal of Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Alsara, Anas
Rafi, Muhammad
Donor-transmitted melanoma after limbal stem cell transplantation
title Donor-transmitted melanoma after limbal stem cell transplantation
title_full Donor-transmitted melanoma after limbal stem cell transplantation
title_fullStr Donor-transmitted melanoma after limbal stem cell transplantation
title_full_unstemmed Donor-transmitted melanoma after limbal stem cell transplantation
title_short Donor-transmitted melanoma after limbal stem cell transplantation
title_sort donor-transmitted melanoma after limbal stem cell transplantation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398008/
https://www.ncbi.nlm.nih.gov/pubmed/28469991
http://dx.doi.org/10.4103/2231-0770.203609
work_keys_str_mv AT alsaraanas donortransmittedmelanomaafterlimbalstemcelltransplantation
AT rafimuhammad donortransmittedmelanomaafterlimbalstemcelltransplantation